This announcement is a separate document:
诺泰生物：关于控股股东、实际控制人提议中期分红暨落实公司2024年度“提质增效重回报”专项行动方案的公告
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement on Proposal of Interim Dividend and Implementation of the 2024 'Improving Quality and Efficiency, Returning Benefits' Special Action Plan by the Controlling Shareholder and Actual Controller
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.